IGI Wins 2023 Champion of Health Equity Pantheon Award from California Life Sciences

Annual Pantheon Awards celebrate California’s leading life sciences innovators

California Life Sciences (CLS), the state’s life sciences trade association, has awarded the Innovative Genomics Institute (IGI) the 2023 Champion of Health Equity Pantheon Award. The award recognizes IGI for their work using genome engineering to create affordable and accessible solutions in human health, climate, and agriculture.

“This award is especially timely,” says IGI Executive Director Brad Ringeisen. “We’re entering the first wave of CRISPR-based therapies and agricultural products available to the public, and we’re proud to be recognized for our efforts to make these advances accessible to the people who need them most.”

“Congratulations to IGI on their well-deserved Pantheon Award win,” says CLS CEO & President, Mike Guerra. “They’re a shining example of California’s exceptional life sciences innovators and entrepreneurs. As we commemorate Pantheon’s 20th anniversary, we celebrate the IGI team and anticipate their continued contributions to science in the years to come.”

Pantheon brings together more than 500 industry pioneers each year to recognize the contributions of leading life sciences innovators in the state. Winners were announced at the awards ceremony on November 1 in San Francisco. In addition to the IGI, Professor John Matsui received the Elizabeth Schar Inspiring Future Leaders Award for his work directing the Biology Scholars Program at UC Berkeley.

Multiple previous Pantheon awardees have had ties to the IGI, including IGI founder Jennifer Doudna, (Rising Star Award, 2013; Life Sciences Leadership Award, 2019), IGI Governance Board member Edward Penhoet (Life Sciences Leadership Award, 2012), and Scribe Therapeutics (Rising Star Award, 2021), founded by IGI entrepreneurial fellow Benjamin Oakes.

Learn more: www.califesciences.org/pantheon 

Media Contact: Andy Murdock, IGI Communications Director: andymurdock@berkeley.edu